MAR 28, 2017 04:39 PM PDT

The Pill May Offer Women Cancer Protection for Decades

WRITTEN BY: Xuan Pham

Ever since men and women understood how to have children, they've also been trying to understand how to prevent this process. Now a study finds a popular form of birth control may carry signifcant anticancer benefits.

 A recent survey conducted by the Centers for Disease Control and Prevention found that a whopping 62 percent of American women of childbearing age are using some form of birth control, exercising their right to choose when to have children, and how many children they want. Of the available methods, oral contraceptives are the most popular, used by around 10.6 million women.

The most popular form of oral contraceptive for women is based on a combination of two hormones: estrogen and progesterone. This “combined pill” tricks the body into not releasing an egg each month, which significantly reduces the opportunity for fertilization by a sperm.

Because the pill modulates the woman’s levels of hormones that are associated with cancer, scientists have also been curious to know if the pill itself can influence cancer risks in women.

In analyzing over 46,000 women who were on the pill, scientists at the University of Aberdeen in the United Kingdom made quite a positive conclusion. Oral contraceptives seem to offer women protection from colorectal, ovarian, and endometrial cancers, as compared with women not on the pill. Furthermore, the protection seem to have a lasting effect, with estimates of at least 30 years.

"Because the study has been going for such a long time we are able to look at the very long-term effects, if there are any, associated with the pill," said Dr. Lisa Iversen, the study’s lead author. In particular, patients in this study were followed for up to 44 years, which makes quite an impressive longitudinal study.

"So the protective benefits from using the pill during their reproductive years are lasting for at least 30 years after women have stopped using the pill," says Dr. Iversen.

The results support the findings of other previous short-term studies, which report links between the pill and decreased risk of ovarian, endometrial cancers, along with ectopic pregnancy and ovarian cysts.

And like other studies that find hints of increased risk of breast and cervical cancer with the pill, the current study also report similar findings. However, they say this increased risk is small and seems to go away within 5 years of stopping the pill.

"These results from the longest-running study in the world into oral contraceptive use are reassuring. Specifically, pill users don't have an overall increased risk of cancer over their lifetime and that the protective effects of some specific cancers last for at least 30 years,” Dr. Iversen concluded.

Additional source: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 19, 2019
Cancer
OCT 19, 2019
Can soda give me cancer?
We all know that excess consumption of sugary drinks like soda and 100% fruit juices are not good for us. The high quantities of sugar in these beverages h...
OCT 19, 2019
Cancer
OCT 19, 2019
Why some cancers receive more research funding
In a new study from Northwestern Medicine, researchers analyzed which types of cancer receive the most and least amounts of research funding. Their results...
OCT 19, 2019
Cancer
OCT 19, 2019
Understanding osteosarcoma in kids and dogs
New research published in the Nature journal, Communications Biology, shows evidence for a comparative study that scientists could use to improve treatment...
OCT 19, 2019
Clinical & Molecular DX
OCT 19, 2019
New Device Improves Accuracy In Lung Cancer Diagnosis
Acute respiratory distress syndrome ARDS occurs when fluid builds up in the alveoli. These tiny elastics sacs, which are responsible for gaseous exchange i...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Promising Drug Encourages Survival in Pancreatic Cancer
Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results ...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Insulin Drug Could Treat Glioblastoma
A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold...
Loading Comments...